Related references
Note: Only part of the references are listed.Suppression of neuropil aggregates and neurological symptoms by an intracellular antibody implicates the cytoplasmic toxicity of mutant huntingtin
Chuan-En Wang et al.
JOURNAL OF CELL BIOLOGY (2008)
Expanded-polyglutamine huntingtin protein suppresses the secretion and production of a chemokine (CCL5/RANTES) by astrocytes
Szu-Yi Chou et al.
JOURNAL OF NEUROSCIENCE (2008)
Microglial activation in presymptomatic Huntington's disease gene carriers
Yen F. Tai et al.
BRAIN (2007)
Selective degeneration in YAC mouse models of Huntington disease
Jeremy M. Van Raamsdonk et al.
BRAIN RESEARCH BULLETIN (2007)
Mitochondrial dysfunction in Huntington's disease:: the bioenergetics of isolated and in situ mitochondria from transgenic mice
Jorge M. A. Oliveira et al.
JOURNAL OF NEUROCHEMISTRY (2007)
Huntington's disease: Pathological mechanisms and therapeutic strategies
Shilpa Ramaswamy et al.
CELL TRANSPLANTATION (2007)
Deficits of glutamate transmission in the striatum of toxic and genetic models of Huntington's disease
Silvia Rossi et al.
NEUROSCIENCE LETTERS (2006)
Mutant huntingtin impairs the post-Golgi trafficking of brain-derived neurotrophic factor but not its Val66Met polymorphism
Daniel del Toro et al.
JOURNAL OF NEUROSCIENCE (2006)
Wild-type huntingtin ameliorates striatal neuronal atrophy but does not prevent other abnormalities in the YAC128 mouse model of Huntington disease
Jeremy M. Van Raamsdonk et al.
BMC NEUROSCIENCE (2006)
Oral uridine pro-drug PN401 is neuroprotective in the R6/2 and N171-82Q mouse models of Huntington's disease
Joel A. Saydoff et al.
NEUROBIOLOGY OF DISEASE (2006)
Mitochondrial-dependent Ca2+ handling in Huntington's disease striatal cells:: Effect of histone deacetylase inhibitors
Jorge M. A. Oliveira et al.
JOURNAL OF NEUROSCIENCE (2006)
Inhibition of 26S proteasome activity by huntingtin filaments but not inclusion bodies isolated from mouse and human brain
Miguel Diaz-Hernandez et al.
JOURNAL OF NEUROCHEMISTRY (2006)
Dopamine release is severely compromised in the R6/2 mouse model of Huntington's disease
MA Johnson et al.
JOURNAL OF NEUROCHEMISTRY (2006)
Involvement of mitochondrial complex II defects in neuronal death produced by N-terminus fragment of mutated Huntingtin
A Benchoua et al.
MOLECULAR BIOLOGY OF THE CELL (2006)
Reduced expression of the TrkB receptor in Huntington's disease mouse models and in human brain
S Ginés et al.
EUROPEAN JOURNAL OF NEUROSCIENCE (2006)
Low stability of Huntington muscle mitochondria against Ca2+ in R6/2 mice
ZZ Gizatullina et al.
ANNALS OF NEUROLOGY (2006)
Selective degeneration and nuclear localization of mutant huntingtin in the YAC128 mouse model of Huntington disease
JM Van Raamsdonk et al.
HUMAN MOLECULAR GENETICS (2005)
3-Nitropropionic acid: a mitochondrial toxin to uncover physiopathological mechanisms underlying striatal degeneration in Huntington's disease
E Brouillet et al.
JOURNAL OF NEUROCHEMISTRY (2005)
Full motor recovery despite striatal neuron loss and formation of irreversible amyloid-like inclusions in a conditional mouse model of Huntington's disease
M Díaz-Hernández et al.
JOURNAL OF NEUROSCIENCE (2005)
Mitochondrial respiration and ATP production are significantly impaired in striatal cells expressing mutant Huntingtin
T Milakovic et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Progressive loss of BDNF in a mouse model of Huntington's disease and rescue by BDNF delivery
C Zuccato et al.
PHARMACOLOGICAL RESEARCH (2005)
Brain-derived neurotrophic factor modulates dopaminergic deficits in a transgenic mouse model of Huntington's disease
JR Pineda et al.
JOURNAL OF NEUROCHEMISTRY (2005)
Neuronal dysfunction in a polyglutamine disease model occurs in the absence of ubiquitin-proteasome system impairment and inversely correlates with the degree of nuclear inclusion formation
AB Bowman et al.
HUMAN MOLECULAR GENETICS (2005)
Early striatal dendrite deficits followed by neuron loss with advanced age in the absence of anterograde cortical brain-derived neurotrophic factor
ZC Baquet et al.
JOURNAL OF NEUROSCIENCE (2004)
Environmental enrichment rescues protein deficits in a mouse model of Huntington's disease, indicating a possible disease mechanism
TL Spires et al.
JOURNAL OF NEUROSCIENCE (2004)
Generalized brain and skin proteasome inhibition in Huntington's disease
H Seo et al.
ANNALS OF NEUROLOGY (2004)
Brain-derived neurotrophic factor regulates the onset and severity of motor dysfunction associated with enkephalinergic neuronal degeneration in Huntington's disease
JM Canals et al.
JOURNAL OF NEUROSCIENCE (2004)
Accumulation of aberrant ubiquitin induces aggregate formation and cell death in polyglutamine diseases
R de Pril et al.
HUMAN MOLECULAR GENETICS (2004)
Mechanism of neurodegenerative disease: role of the ubiquitin proteasome system
L Petrucelli et al.
ANNALS OF MEDICINE (2004)
Neuronal vulnerability following inhibition of mitochondrial complex II: a possible ionic mechanism for Huntington's disease
E Saulle et al.
MOLECULAR AND CELLULAR NEUROSCIENCE (2004)
NMDA receptor function in mouse models of Huntington disease
C Cepeda et al.
JOURNAL OF NEUROSCIENCE RESEARCH (2001)
Loss of huntingtin-mediated BDNF gene transcription in Huntington's disease
C Zuccato et al.
SCIENCE (2001)
Altered proteasomal function due to the expression of polyglutamine-expanded truncated N-terminal huntingtin induces apoptosis by caspase activation through mitochondrial cytochrome c release
NR Jana et al.
HUMAN MOLECULAR GENETICS (2001)
Down-regulation of the neurotrophin receptor TrkB following ligand binding - Evidence for an involvement of the proteasome and differential regulation of TrkA and TrkB
MT Sommerfeld et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
Long glutamine tracts cause nuclear localization of a novel form of huntingtin in medium spiny striatal neurons in Hdh(Q92) and Hdh(Q111) knock-in mice
VC Wheeler et al.
HUMAN MOLECULAR GENETICS (2000)
Share Paper
